{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:21:34Z","timestamp":1760059294394,"version":"build-2065373602"},"reference-count":47,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T00:00:00Z","timestamp":1748908800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2024YFC2309501","82301185","2019SKLID602","2016YFE0107600"],"award-info":[{"award-number":["2024YFC2309501","82301185","2019SKLID602","2016YFE0107600"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["2024YFC2309501","82301185","2019SKLID602","2016YFE0107600"],"award-info":[{"award-number":["2024YFC2309501","82301185","2019SKLID602","2016YFE0107600"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"SKLID key project","award":["2024YFC2309501","82301185","2019SKLID602","2016YFE0107600"],"award-info":[{"award-number":["2024YFC2309501","82301185","2019SKLID602","2016YFE0107600"]}]},{"name":"International Cooperation Grant from the Ministry of Science and Technology of China","award":["2024YFC2309501","82301185","2019SKLID602","2016YFE0107600"],"award-info":[{"award-number":["2024YFC2309501","82301185","2019SKLID602","2016YFE0107600"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathogens"],"abstract":"<jats:p>We investigated HIV-1 immune evasion mechanisms in a slow progressor (CBJC515) by constructing pseudoviruses expressing autologous Env proteins. Intriguingly, all pseudoviruses exhibited resistance to the broadly neutralizing antibody (bNAb) PGT135. Using site-directed mutagenesis and chimeric Env construction, we identified distinct escape mechanisms: early 2005 strains lost the N332 glycan site, while 2006\/2008 strains retained key epitopes but developed resistance through structural modifications in the V1\/V4\/C2 regions or acquired novel N-glycosylation sites (N398\/N611). These findings provide insights into how HIV-1 can escape from N332-directed bNAb responses without altering the epitope itself. Furthermore, chimeric experiments also elucidated regional co-evolution and functional maintenance: the V1V2 region broadly interfered with envelope protein function, while the V3 region may exhibit compensatory activity, restoring functionality and mitigating deleterious polymorphisms in other regions to keep Env antigenic diversity. These results offer valuable mechanistic clues that may inform the development of next-generation HIV-1 vaccines.<\/jats:p>","DOI":"10.3390\/pathogens14060556","type":"journal-article","created":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T11:55:52Z","timestamp":1748951752000},"page":"556","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multiple Mechanisms of HIV-1 Resistance to PGT135 in a Chinese Subtype B\u2019 Slow Progressor"],"prefix":"10.3390","volume":"14","author":[{"given":"Yuanyuan","family":"Hu","sequence":"first","affiliation":[{"name":"Guangxi Key Laboratory of AIDS Prevention and Treatment & Biosafety III Laboratory, Guangxi Medical University, Nanning 530021, China"},{"name":"National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Center for AIDS\/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shasha","family":"Sun","sequence":"additional","affiliation":[{"name":"National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Center for AIDS\/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9391-9707","authenticated-orcid":false,"given":"Ying","family":"Liu","sequence":"additional","affiliation":[{"name":"National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Center for AIDS\/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Ren","sequence":"additional","affiliation":[{"name":"National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Center for AIDS\/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6552-9357","authenticated-orcid":false,"given":"Xintao","family":"Hu","sequence":"additional","affiliation":[{"name":"National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Center for AIDS\/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhua","family":"Ruan","sequence":"additional","affiliation":[{"name":"National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Center for AIDS\/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liying","family":"Ma","sequence":"additional","affiliation":[{"name":"National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Center for AIDS\/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7534-5124","authenticated-orcid":false,"given":"Hao","family":"Liang","sequence":"additional","affiliation":[{"name":"Guangxi Key Laboratory of AIDS Prevention and Treatment & Biosafety III Laboratory, Guangxi Medical University, Nanning 530021, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9416-190X","authenticated-orcid":false,"given":"Yiming","family":"Shao","sequence":"additional","affiliation":[{"name":"National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Center for AIDS\/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunxue","family":"Hong","sequence":"additional","affiliation":[{"name":"National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Center for AIDS\/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sen","family":"Zou","sequence":"additional","affiliation":[{"name":"National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Center for AIDS\/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China"},{"name":"NHC Key Laboratory of Biotechnology of Antibiotics, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9317-650X","authenticated-orcid":false,"given":"Yanling","family":"Hao","sequence":"additional","affiliation":[{"name":"National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Center for AIDS\/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1128\/JVI.01583-08","article-title":"Frequency and phenotype of human immunodeficiency virus envelope-specific B cells from patients with broadly cross-neutralizing antibodies","volume":"83","author":"Klein","year":"2009","journal-title":"J. Virol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1128\/JVI.06091-11","article-title":"Longitudinal analysis of early HIV-1-specific neutralizing activity in an elite neutralizer and in five patients who developed cross-reactive neutralizing activity","volume":"86","author":"Euler","year":"2012","journal-title":"J. Virol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Mikell, I., Sather, D.N., Kalams, S.A., Altfeld, M., Alter, G., and Stamatatos, L. (2011). Characteristics of the earliest cross-neutralizing antibody response to HIV-1. PLoS Pathog., 7.","DOI":"10.1371\/annotation\/8b3b24b5-d4ed-483a-b233-0a88513ad499"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1097\/QAD.0b013e32833243e7","article-title":"Prevalence of cross-reactive HIV-1-neutralizing activity in HIV-1-infected patients with rapid or slow disease progression","volume":"23","author":"Euler","year":"2009","journal-title":"AIDS"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1016\/j.cell.2024.04.033","article-title":"Vaccine induction of heterologous HIV-1-neutralizing antibody B cell lineages in humans","volume":"187","author":"Williams","year":"2024","journal-title":"Cell"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/nsmb.2594","article-title":"Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120","volume":"20","author":"Kong","year":"2013","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1038\/s41594-023-01062-z","article-title":"Trapping the HIV-1 V3 loop in a helical conformation enables broad neutralization","volume":"30","author":"Glogl","year":"2023","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e0268623","DOI":"10.1128\/mbio.02686-23","article-title":"Alternative substitutions of N332 in HIV-1(AD8) gp120 differentially affect envelope glycoprotein function and viral sensitivity to broadly neutralizing antibodies targeting the V3-glycan","volume":"15","author":"Jeffy","year":"2024","journal-title":"mBio"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3924","DOI":"10.1038\/s41467-024-48139-x","article-title":"Contemporary HIV-1 consensus Env with AI-assisted redesigned hypervariable loops promote antibody binding","volume":"15","author":"Bai","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"236ra63","DOI":"10.1126\/scitranslmed.3008104","article-title":"Promiscuous glycan site recognition by antibodies to the high-mannose patch of gp120 broadens neutralization of HIV","volume":"6","author":"Sok","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12977-016-0279-4","article-title":"HIV-1 escapes from N332-directed antibody neutralization in an elite neutralizer by envelope glycoprotein elongation and introduction of unusual disulfide bonds","volume":"13","author":"Burton","year":"2016","journal-title":"Retrovirology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.chom.2019.07.016","article-title":"HIV-1 Neutralizing Antibody Signatures and Application to Epitope-Targeted Vaccine Design","volume":"26","author":"Bricault","year":"2019","journal-title":"Cell Host Microbe"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12977-016-0297-2","article-title":"HIV-1 clade C escapes broadly neutralizing autologous antibodies with N332 glycan specificity by distinct mechanisms","volume":"13","author":"Deshpande","year":"2016","journal-title":"Retrovirology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e00094-19","DOI":"10.1128\/JVI.00094-19","article-title":"A Highly Unusual V1 Region of Env in an Elite Controller of HIV Infection","volume":"93","author":"Silver","year":"2019","journal-title":"J. Virol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e00828-17","DOI":"10.1128\/JVI.00828-17","article-title":"Cooperation between Strain-Specific and Broadly Neutralizing Responses Limited Viral Escape and Prolonged the Exposure of the Broadly Neutralizing Epitope","volume":"91","author":"Anthony","year":"2017","journal-title":"J. Virol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.immuni.2018.12.017","article-title":"An Antigenic Atlas of HIV-1 Escape from Broadly Neutralizing Antibodies Distinguishes Functional and Structural Epitopes","volume":"50","author":"Dingens","year":"2019","journal-title":"Immunity"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/0092-8674(86)90778-6","article-title":"Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III\/LAV, the retrovirus of AIDS","volume":"45","author":"Starcich","year":"1986","journal-title":"Cell"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nature01470","article-title":"Antibody neutralization and escape by HIV-1","volume":"422","author":"Wei","year":"2003","journal-title":"Nature"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev-immunol-030409-101256","article-title":"The role of antibodies in HIV vaccines","volume":"28","author":"Mascola","year":"2010","journal-title":"Annu. Rev. Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Dam, K.A., Fan, C., Yang, Z., and Bjorkman, P.J. (2023). Structural characterization of HIV-1 Env heterotrimers bound to one or two CD4 receptors reveals intermediate Env conformations. bioRxiv.","DOI":"10.1101\/2023.01.27.525985"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nature03327","article-title":"Structure of an unliganded simian immunodeficiency virus gp120 core","volume":"433","author":"Chen","year":"2005","journal-title":"Nature"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/nature10696","article-title":"Structure of HIV-1 gp120 V1\/V2 domain with broadly neutralizing antibody PG9","volume":"480","author":"McLellan","year":"2011","journal-title":"Nature"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nsmb.3051","article-title":"Crystal structure, conformational fixation and entry-related interactions of mature ligand-free HIV-1 Env","volume":"22","author":"Kwon","year":"2015","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12985-014-0221-0","article-title":"HIV-1 vaccine immunogen design strategies","volume":"12","author":"Mann","year":"2015","journal-title":"Virol. J."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12977-016-0285-6","article-title":"Buffering deleterious polymorphisms in highly constrained parts of HIV-1 envelope by flexible regions","volume":"13","author":"Gasser","year":"2016","journal-title":"Retrovirology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/1742-4690-10-114","article-title":"Genetic diversity of the highly variable V1 region interferes with Human Immunodeficiency Virus type 1 envelope functionality","volume":"10","author":"Hamoudi","year":"2013","journal-title":"Retrovirology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1099\/vir.0.043802-0","article-title":"Profiles of neutralizing antibody response in chronically human immunodeficiency virus type 1 clade B\u2019-infected former plasma donors from China naive to antiretroviral therapy","volume":"93","author":"Hu","year":"2012","journal-title":"J. Gen. Virol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.3389\/fmicb.2019.01096","article-title":"Characteristics of Envelope Genes in a Chinese Chronically HIV-1 Infected Patient With Broadly Neutralizing Activity","volume":"10","author":"Zhang","year":"2019","journal-title":"Front. Microbiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"5844","DOI":"10.1128\/JVI.07139-11","article-title":"Selection pressure on HIV-1 envelope by broadly neutralizing antibodies to the conserved CD4-binding site","volume":"86","author":"Wu","year":"2012","journal-title":"J. Virol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.immuni.2012.11.011","article-title":"Vaccine induction of antibodies against a structurally heterogeneous site of immune pressure within HIV-1 envelope protein variable regions 1 and 2","volume":"38","author":"Liao","year":"2013","journal-title":"Immunity"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nature10373","article-title":"Broad neutralization coverage of HIV by multiple highly potent antibodies","volume":"477","author":"Walker","year":"2011","journal-title":"Nature"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e80562","DOI":"10.1371\/journal.pone.0080562","article-title":"Computational prediction of broadly neutralizing HIV-1 antibody epitopes from neutralization activity data","volume":"8","author":"Ferguson","year":"2013","journal-title":"PLoS ONE"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa0908492","article-title":"Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand","volume":"361","author":"Pitisuttithum","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nature11519","article-title":"Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2","volume":"490","author":"Rolland","year":"2012","journal-title":"Nature"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Marichannegowda, M., Heredia, A., Wang, Y., and Song, H. (2024). Genetic signatures in the highly virulent subtype B HIV-1 conferring immune escape to V1\/V2 and V3 broadly neutralizing antibodies. bioRxiv.","DOI":"10.1101\/2024.03.13.584899"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.cell.2014.06.022","article-title":"Cooperation of B cell lineages in induction of HIV-1-broadly neutralizing antibodies","volume":"158","author":"Gao","year":"2014","journal-title":"Cell"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.cell.2016.02.022","article-title":"Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic Antibody","volume":"165","author":"Bonsignori","year":"2016","journal-title":"Cell"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"4882","DOI":"10.1128\/JVI.03424-12","article-title":"Multiple pathways of escape from HIV broadly cross-neutralizing V2-dependent antibodies","volume":"87","author":"Moore","year":"2013","journal-title":"J. Virol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/s41586-023-06639-8","article-title":"Intermediate conformations of CD4-bound HIV-1 Env heterotrimers","volume":"623","author":"Dam","year":"2023","journal-title":"Nature"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e1009257","DOI":"10.1371\/journal.ppat.1009257","article-title":"The C3\/465 glycan hole cluster in BG505 HIV-1 envelope is the major neutralizing target involved in preventing mucosal SHIV infection","volume":"17","author":"Charles","year":"2021","journal-title":"PLoS Pathog."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.molmed.2022.08.010","article-title":"Antibody class-switching as a strategy to improve HIV-1 neutralization","volume":"28","author":"Scheepers","year":"2022","journal-title":"Trends Mol. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"802","DOI":"10.3390\/v1030802","article-title":"Maturation Pathways of Cross-Reactive HIV-1 Neutralizing Antibodies","volume":"1","author":"Xiao","year":"2009","journal-title":"Viruses"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.cell.2013.03.018","article-title":"Somatic mutations of the immunoglobulin framework are generally required for broad and potent HIV-1 neutralization","volume":"153","author":"Klein","year":"2013","journal-title":"Cell"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/nri2801","article-title":"Structure-function relationships of HIV-1 envelope sequence-variable regions refocus vaccine design","volume":"10","author":"Cardozo","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e2169196","DOI":"10.1080\/22221751.2023.2169196","article-title":"Substitution of gp120 C4 region compensates for V3 loss-of-fitness mutations in HIV-1 CRF01_AE co-receptor switching","volume":"12","author":"Yu","year":"2023","journal-title":"Emerg. Microbes Infect."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Liu, K., Guo, F., Ma, Y., Yu, X., Fu, X., Li, W., and Han, W. (2023). Functionalized Fullerene Potentially Inhibits SARS-CoV-2 Infection by Modulating Spike Protein Conformational Changes. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241914471"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Gai, Y., Duan, S., Wang, S., Liu, K., Yu, X., Yang, C., Li, G., Zhou, Y., Yu, B., and Wu, J. (2024). Design of Vif-Derived Peptide Inhibitors with Anti-HIV-1 Activity by Interrupting Vif-CBFbeta Interaction. Viruses, 16.","DOI":"10.3390\/v16040490"}],"container-title":["Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-0817\/14\/6\/556\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:46:43Z","timestamp":1760032003000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-0817\/14\/6\/556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,3]]},"references-count":47,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["pathogens14060556"],"URL":"https:\/\/doi.org\/10.3390\/pathogens14060556","relation":{},"ISSN":["2076-0817"],"issn-type":[{"type":"electronic","value":"2076-0817"}],"subject":[],"published":{"date-parts":[[2025,6,3]]}}}